Home
Distretto Toscano Scienze della Vita
  • Login
    • EN
    • IT
  • THE CLUSTER
    • About us
    • What we do
    • Services4Members
    • Our Members & Partners
    • The Team
    • How to become a member
  • NETWORK
    • All Members
    • Search for affiliates
    • Search for facilities
    • Search for services/products
  • Tech Board
    • Partnership opportunities from the rest of the world
    • Request/Offer
    • Research Infrastructures & Technology Platforms
    • Reports&Docs
  • NEWS
  • Home

The Cluster Network

GALILEO RESEARCH

  • Pharma/Biopharma
  • Nutraceutics, well-being and food safety
  • Company information
  • Profile
  • Products/Services/Instruments
  • Additional info
Business Type: 
Srl
Company Size: 
Small
Website: http://www.galileoresearch.it
 
 +39 050 3154283
VAT number: 
01855640502
Registered office address:
Via del Paradiso, 6 - 56019 - Località Migliarino Pisano, Vecchiano-PI


Overview: 
Galileo Research is an Italian biotech company with a pipeline very focused on projects in the oncology and central nervous system (TALL-104, cell therapy), founded on a solid intellectual property base and with national and international partnerships of absolute value. Galileo was born from the research experience of Abiogen Pharma, and is authorized to carry out studies in GLP. Galileo carries out research and development services for the various stages of drug discovery and lead optimization (ADME studies, proteomics, epigenetics, toxicogenomics, pharmacokinetics, bioanalytics), as well as tests for the development of products in the nutraceutical, chemical and cosmetic sectors.
Profile: 

Galileo Research is the continuation of an industrial path first taken by Abiogen Pharma, where the internal R&D Division, started in 1997, represented the core of energy and innovation, now transformed to focus in a more corporate environment, where the potential of the project pipeline can gain maximum benefit from scientific and financial opportunities. Galileo Research maintains the Abiogen’s Research Centre structure in Migliarino (close to Pisa - Italy) and its entire group of researchers. The experience and expertise of Galileo’s researchers have for years contributed to the success of Italian firms such as Istituto Gentili and Abiogen Pharma. In the last few years Galileo Research has delivered 13 pre-clinical and clinical compounds across all major therapeutic categories, several of them being object of partnership. Galileo Research is supported by a management team of high reputation with a track record of success in R&D management, advised by an outstanding Scientific Board. Galileo Research has a GLP certified Testing Facility. Product development studies at Galileo Research are performed according to ICH, OECD, REACH guidelines, in full compliance with the Good Laboratory Practice (GLP) regulations (certified by the Italian Health Authorities since 1990) and supervised by an external Quality Assurance Service. The scientific staff has extensive experience in research and preclinical development, particularly skilled in animal toxicology, genotoxicity, ADME and in vivo models of diseases. Moreover, it has strong knowledge in gene expression profiling, RT-PCR, recombinant protein expression, monoclonal antibody preparation, 2-D electrophoresis and other advanced technologies. Galileo Research boasts a vast and active network of experience and expertise with a number of scientific laboratories in the Tuscany Region where Galileo’s projects can also benefit from the extensive knowledge and excellence of the Territory.

Read more

Sectors :
Pharma/BiopharmaBiologic drugsCell therapy, Stem cells
 Related activities and servicesAnalytical Services
  Research & Development
  Screening services, drug discovery
  Testing/validation services
  Genomics, proteomics, other -omics

Activity type: 
Design & prototyping
Research & development
Services, consulting
Founding Year: 
2007
Standards and Certificates: 
ICH, REACH in GLP
Country already served: 
Italy

Products/Services

  • Galileo provides research and development services for the various stages of drug discovery and lead optimization. In particular: Drug discovery, solubility test, also in gastric and intestinal fluids, determination of coefficient of distribution, permeability, stability, bioavailability, interaction with CYP450, 2nd phase metabolic studies, in vivo and in vitro toxicity, genotoxicity, proteomic studies, epigenetic profile.
  • Lead optimisation, ADME, in vitro and in vivo drug metabolism and pharmacokinetics (DMPK) studies, bioanalytic services
  • Toxicological and safety tests in REACH
  • In vitro and in vivo toxicity and safety tests to support claim nutraceuticals
  • In vitro dermatological and ophthalmologic tests for cosmetic applications

Share Facebook Twitter Linkedin





Looking for services, facilities , collaborations for a project in Life Sciences?



  • MEMBERS


  • FACILITIES

  • SERVICES
    PRODUCTS

The cluster network provides a large panel of services and products for the growth of life sciences in Tuscany.

 

Here you can find an updated list of the facilties and equipments that the Cluster network makes available for the development of business projects and research activities.

 

The updated map with all members of the Cluster. Here you can find contacts of companies, research groups and organisations connected to the Tuscany cluster.

 

Newsletter

Join the newsletter to keep updated about all the news, events, opportunities in life sciences

Tweets by DistrettoTSV

Contact Us

at Fondazione Toscana Life Sciences
Managing Body of Tuscany Life Sciences Cluster

  • Address: Via Fiorentina 1 – 53100 Siena - Italy
  • Email: info@scienzedellavita.it

Editorial board

  • Email: redazione@meetthelifesciences.it

Follow us

Privacy >

Fondazione Toscana Life Sciences - Progetto co-finanziato nel quadro del POR FESR Toscana 2014-2020
Fondazione Toscana Life Sciences - Progetto co-finanziato nel quadro del POR FESR Toscana 2014-2020